EdgarLookup

Protara Therapeutics, Inc. — All Filings

772 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 144 3 3/A 4 4/A 424B3 424B4 424B5 424B7 425 5 8-A12B 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT PRE 14A REGDEX REGDEX/A RW S-1 S-1/A S-1MEF S-3 S-3/A S-3MEF S-4 S-4/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
10-K ANNUAL REPORT 0001213900-26-025433 Mar 10, 2026 Dec 31, 2025
8-K CURRENT REPORT 0001213900-26-025432 Mar 10, 2026
144 0001104659-26-024805 Mar 6, 2026
144 0001104659-26-024803 Mar 6, 2026
424B7 PROSPECTUS SUPPLEMENT 0001213900-26-024668 Mar 6, 2026
144 0001104659-26-023665 Mar 4, 2026
144 0001104659-26-023663 Mar 4, 2026
SCHEDULE 13G 0001104659-26-022274 Mar 2, 2026
144 0001104659-26-019854 Feb 25, 2026
144 0001104659-26-019853 Feb 25, 2026
144 0001104659-26-019328 Feb 24, 2026
144 0001104659-26-019326 Feb 24, 2026
8-K CURRENT REPORT 0001213900-26-019617 Feb 24, 2026 Feb 23, 2026
424B7 PROSPECTUS SUPPLEMENT 0001213900-26-010806 Feb 2, 2026
4 PRIMARY DOCUMENT 0001213900-26-008222 Jan 27, 2026 Jan 26, 2026
4 PRIMARY DOCUMENT 0001213900-26-008221 Jan 27, 2026 Jan 26, 2026
4 PRIMARY DOCUMENT 0001213900-26-008224 Jan 27, 2026 Jan 26, 2026
4 PRIMARY DOCUMENT 0001213900-26-008223 Jan 27, 2026 Jan 26, 2026
4 PRIMARY DOCUMENT 0001213900-26-006711 Jan 22, 2026 Jan 20, 2026
4 PRIMARY DOCUMENT 0001213900-26-006709 Jan 22, 2026 Jan 20, 2026
4 PRIMARY DOCUMENT 0001213900-26-006708 Jan 22, 2026 Jan 20, 2026
4 PRIMARY DOCUMENT 0001213900-26-006707 Jan 22, 2026 Jan 20, 2026
4 PRIMARY DOCUMENT 0001213900-26-006231 Jan 21, 2026 Jan 16, 2026
4 PRIMARY DOCUMENT 0001213900-26-006230 Jan 21, 2026 Jan 16, 2026
4 PRIMARY DOCUMENT 0001213900-26-006229 Jan 21, 2026 Jan 16, 2026
4 PRIMARY DOCUMENT 0001213900-26-006228 Jan 21, 2026 Jan 16, 2026
4 PRIMARY DOCUMENT 0001213900-26-006226 Jan 21, 2026 Jan 16, 2026
4 PRIMARY DOCUMENT 0001213900-26-006225 Jan 21, 2026 Jan 16, 2026
SCHEDULE 13G/A 0002012383-26-000705 Jan 21, 2026
8-K CURRENT REPORT 0001213900-25-121687 Dec 15, 2025
424B7 PROSPECTUS SUPPLEMENT 0001213900-25-119667 Dec 9, 2025
8-K CURRENT REPORT 0001213900-25-119242 Dec 8, 2025 Dec 4, 2025
424B5 PROSPECTUS SUPPLEMENT 0001213900-25-118744 Dec 5, 2025
424B5 PROSPECTUS SUPPLEMENT 0001213900-25-118304 Dec 4, 2025
8-K CURRENT REPORT 0001213900-25-117577 Dec 3, 2025
8-K CURRENT REPORT 0001213900-25-112383 Nov 19, 2025
10-Q QUARTERLY REPORT 0001213900-25-107881 Nov 10, 2025 Sep 30, 2025
8-K CURRENT REPORT 0001213900-25-107873 Nov 10, 2025
SCHEDULE 13G/A 0001415889-25-022020 Aug 14, 2025
S-8 REGISTRATION STATEMENT 0001213900-25-074386 Aug 11, 2025
10-Q QUARTERLY REPORT 0001213900-25-073942 Aug 11, 2025 Jun 30, 2025
8-K CURRENT REPORT 0001213900-25-073937 Aug 11, 2025
SCHEDULE 13G 0002052113-25-003111 Jul 17, 2025
4 PRIMARY DOCUMENT 0001213900-25-061772 Jul 7, 2025 Jun 24, 2025
4 PRIMARY DOCUMENT 0001213900-25-059655 Jun 30, 2025 Jun 26, 2025
4 PRIMARY DOCUMENT 0001213900-25-054286 Jun 13, 2025 Jun 12, 2025
4 PRIMARY DOCUMENT 0001213900-25-054285 Jun 13, 2025 Jun 12, 2025
4 PRIMARY DOCUMENT 0001213900-25-054288 Jun 13, 2025 Jun 12, 2025
4 PRIMARY DOCUMENT 0001213900-25-054284 Jun 13, 2025 Jun 12, 2025
4 PRIMARY DOCUMENT 0001213900-25-054287 Jun 13, 2025 Jun 12, 2025